Identification of Drug Resistant Candida auris

Area of Science:

• Medical Mycology
• Infectious Diseases
• Public Health Microbiology

Background:

• Candida auris is a multidrug-resistant yeast causing invasive infections and healthcare-associated outbreaks globally.
• Its drug resistance, transmission dynamics, and potential for emergence pose significant public health challenges.
• Current outbreak responses are hindered by limited treatments, inadequate disinfection, and diagnostic tool limitations like misidentification and long turnaround times.

Purpose of the Study:

• To review available methods for Candida auris detection, identification, and antifungal susceptibility determination.
• To discuss the advantages and limitations of current and emerging diagnostic strategies.
• To highlight the potential of culture-independent methods for faster diagnosis.

Main Methods:

• Literature review of diagnostic methods for Candida auris.
• Analysis of traditional culture-based and molecular diagnostic techniques.
• Evaluation of emerging culture-independent diagnostic approaches.

Main Results:

• Common diagnostic platforms often misidentify Candida auris due to incomplete reference databases.
• Limited understanding of the correlation between minimal inhibitory concentration (MIC) values and clinical outcomes impedes breakpoint establishment.
• Newer diagnostic methods, particularly culture-independent ones, offer improved accuracy and faster results.

Conclusions:

• Accurate and rapid diagnostics are essential for effective patient management and infection control of Candida auris.
• Advancements in diagnostic technologies, especially culture-independent methods, are critical to combatting the spread of this resistant pathogen.
• Further research is needed to establish Candida auris-specific breakpoints for antifungal susceptibility testing.